Relapsed/Refractory Autoimmune Diseases

Immunology·MeSH: Autoimmune Diseases
3 drugs in development·1 company·3 clinical trials

Drug Pipeline by Phase

Compare drugs

LCAR-AIO T cells vs LUCAR-DKS1 NK cellsLCAR-AIO T cells vs LUCAR-G79 T cells

Frequently asked questions

How many drugs are in development for Relapsed/Refractory Autoimmune Diseases?

BioSniper tracks 3 drugs in development for Relapsed/Refractory Autoimmune Diseases across 1 company.

How many clinical trials target Relapsed/Refractory Autoimmune Diseases?

There are 3 clinical trials targeting Relapsed/Refractory Autoimmune Diseases tracked by BioSniper.

Deep-dive into Relapsed/Refractory Autoimmune Diseases

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Relapsed/Refractory Autoimmune Diseases — Drugs in Development & Clinical Trials | BioSniper